Bcl-2 expression is associated with poor prognosis of solitary plasmacytoma of bone

Annals of Hematology

Volumn 93, Issue 3, 2014, Pages 471-477

  Guo, Shanqi ^a   Zhi, Yaqin ^a   Yang, Hongliang ^a   Yu, Yong ^a   Wang, Yafei ^a   Zhang, Jin ^b   Wang, Guowen ^b   Zhang, Lianyu ^a   Sun, Baocun ^a   Zhang, Yizhuo ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Bcl 2; Clinical features; Prognosis; Solitary plasmacytoma of bone

Indexed keywords

ADULT; AGED; BONE AND BONES; BONE NEOPLASMS; COHORT STUDIES; CYCLIN D1; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM PROTEINS; PLASMACYTOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84894291804     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1897-8     Document Type: Article

References (29)

1. Kilciksiz S, Karakoyun-Celik O, Agaoglu FY et al (2012) A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. Sci World J 2012:895765
2. Lorsbach RB, Hsi ED, Dogan A et al (2011) Plasma cell myeloma and related neoplasms. Am J Clin Pathol 136(2):168-182
3. Dimopoulos MA, Moulopoulos LA, Maniatis A et al (2000 Sep 15) Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood 96(6):2037-2044
4. Phromnoi K, Prasad S, Gupta SC et al (2011) Dihydroxypentamethoxyflavone down-regulates constitutive and inducible signal transducers and activators of transcription-3 through the induction of tyrosine phosphatase SHP-1. Mol Pharmacol 80(5):889-899
5. Liang P, Cheng SH, Cheng CK et al (2013) Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma. Haematologica 98(2):288-295
6. Bergsagel PL, Kuehl WM, Zhan F et al (2005) Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106(1):296-303
7. Hasegawa T, Suzuki K, Sakamoto C et al (2003) Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia. Blood 101(3):1164-1171
8. Aggarwal BB, Sethi G, Ahn KS et al (2006) Targeting signal transducer and activator of transcription 3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 1091:151-169
9. SH Swerdlow EC, Harris NL, et al. (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, International Agency for Research on Cancer (IARC) Lyon, France
10. Hughes M, Soutar R, Lucraft H et al (2009) Guidelines on the diagnosis and management of solitary plasmacytoma of bone, extramedullary plasmacytoma and multiple solitary plasmacytomas. British Committee for Standards in Haematology, London, 14 p
11. Dingli D, Kyle RA, Rajkumar SV et al (2006) Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood 108(6):1979-1983
12. Soutar R, Lucraft H, Jackson G et al (2004) Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) 16(6):405-413
13. Jyothirmayi R, Gangadharan VP, Nair MK et al (1997) Radiotherapy in the treatment of solitary plasmacytoma. Br J Radiol 70:511-516
14. Dimopoulos MA, Hamilos G (2002) Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol 3:255-259
15. Weber DM (2005) Solitary bone and extramedullary plasmacytoma. Hematology 1:373-376
16. Kim PJ, Hicks RJ, Wirth A et al (2009) Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma. Int J Radiat Oncol Biol Phys 74(3):740-746
17. Hu K, Yahalom J (2000) Radiotherapy in the management of plasma cell tumors. Oncol (Williston Park) 14(1):101-108
18. Chao MW, Gibbs P, Wirth A (2005) Radiotherapy in the management of solitary extramedullary plasmacytoma. Intern Med J 35(4):211-215
19. Suh YG, Suh CO, Kim JS et al (2012 Nov) Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors. Ann Hematol 91(11):1785-1793
20. Tsang RW, Gospodarowicz MK, Pintilie M (2001) Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 50(1):113-120
21. Kilciksiz S, Celik OK, Pak Y et al (2008) Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party. Am J Hematol 83(9):702-707
22. Knobel D, Zouhair A, Tsang RW et al (2006) Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer 6:118
23. Ozsahin M, Tsang RW, Poortmans P et al (2006) Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys 64(1):210-217
24. Zuo Z, Tang Y, Bi CF et al (2011) Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases. Diagn Pathol 6:123
25. Visco C, Tzankov A, Xu-Monette ZY et al (2013) Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica 98(2):255-263
26. Zhang Y, Zhao X, Tao J (2012) Epigenetics, c-Myc and aggressive B-cell lymphomas. Oncotarget 3(11):1264-1265
27. Rutsch S, Neppalli VT, Shin DM et al (2010) IL-6 and MYC collaborate in plasma cell tumor formation in mice. Blood 115(9):1746-1754
28. Khuda SE, Loo WM, Janz S et al (2008) Deregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitors. J Immunol 181(11):7537-7549
29. Yang C, Lee H, Jove V et al (2013) Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer. PLoS One 8(1):e54029